PDE IV inhibiting compounds, compositions and methods of treatment
US6204275A · kind A · utility
35Cited by
5References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2000 |
| Grant date | Mar 20, 2001 |
| Priority date | — |
| Expiry date | Feb 25, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses compounds of Formula I useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE IV). ##STR1## The invention also encompasses certain pharmaceutical compositions and methods for treatment of diseases by inhibition of PDE IV, resulting in an elevation of cAMP, comprising the use of compounds of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.